ACA Stock Arcosa (ACA, $145.45) price moved above its 50-day Moving Average on September 17, 2026
at Tickeron.com
This price move could indicate a change in the trend, and may be a buy signal for investors. A.I.dvisor found 40 similar cases, and were successful. Based on this data, the odds of success are
ACA sees its Stochastic Oscillator recovers from oversold territory
On September 17, 2026, the Stochastic Oscillator for ACA moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 63 instances where the indicator left the oversold zone. In 43 of the 63 cases the stock moved higher in the following days. This puts the odds of a move higher at over 68%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on September 17, 2026. You may want to consider a long position or call options on ACA as a result. In 65 of 104 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 62%.
ACA moved above its 50-day moving average on September 17, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +0.48% 3-day Advance, the price is estimated to grow further. Considering data from situations where ACA advanced for three days, in 195 of 312 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.
The Aroon Indicator entered an Uptrend today. In 114 of 219 cases where ACA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 52%.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 55%.
ACA broke above its upper Bollinger Band on September 18, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 16 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. ACA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 50 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 74 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.394) is normal, around the industry mean (16.717). P/E Ratio (32.467) is within average values for comparable stocks, (204.092). Projected Growth (PEG Ratio) (1.850) is also within normal values, averaging (3.519). Dividend Yield (0.001) settles around the average of (0.007) among similar stocks. P/S Ratio (2.444) is also within normal values, averaging (2.926).
The Tickeron PE Growth Rating for this company is 83 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.